Date |
Time |
Source |
Heading |
3/27/2024 | 08:00 | GLOBE | Vaxart to Present at World Vaccine Congress Washington 2024.. |
3/20/2024 | 08:00 | GLOBE | Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing.. |
3/14/2024 | 16:01 | GLOBE | Vaxart Provides Business Update and Reports Full Year 2023.. |
3/14/2024 | 07:41 | IHMARKETNEWS | U.S. Stock Futures Rise Ahead Of PPI and Retail Sales; Oil.. |
3/07/2024 | 08:00 | GLOBE | Vaxart to Host Full Year 2023 Business Update and Financial.. |
3/06/2024 | 09:23 | EDGAR2 | Form 8-K - Current report |
3/06/2024 | 08:00 | GLOBE | Vaxart, Inc. Appoints Steven Lo as President, Chief.. |
2/29/2024 | 16:30 | EDGAR2 | Form 8-K - Current report |
2/15/2024 | 16:10 | EDGAR2 | Form 8-K - Current report |
2/13/2024 | 17:16 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
2/05/2024 | 08:00 | GLOBE | Vaxart Announces Publication in Vaccines of Non-Human.. |
2/02/2024 | 16:49 | EDGAR2 | Form 8-K/A - Current report: [Amend] |
1/19/2024 | 17:14 | EDGAR2 | Form 8-K - Current report |
1/19/2024 | 16:30 | EDGAR2 | Form SC 13G - Statement of acquisition of beneficial.. |
1/19/2024 | 08:30 | GLOBE | Vaxart Receives $9.27 Million BARDA Project NextGen Award to.. |
1/16/2024 | 17:18 | EDGAR2 | Form 8-K - Current report |
1/16/2024 | 09:25 | GLOBE | Vaxart Announces $10.0 Million Registered Direct Offering.. |
1/16/2024 | 09:22 | GLOBE | Vaxart, Inc. Announces Management Change |
1/16/2024 | 09:19 | EDGAR2 | Form 8-K - Current report |
12/21/2023 | 08:00 | GLOBE | Vaxart Announces Last Subject Dosed in Phase 1 Trial of Its.. |
11/02/2023 | 16:16 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
11/02/2023 | 16:11 | EDGAR2 | Form 8-K - Current report |
11/02/2023 | 16:01 | GLOBE | Vaxart Provides Business Update and Reports Third Quarter.. |
11/02/2023 | 08:00 | GLOBE | Vaxart Doses First Subject in Phase 1 Trial of Its Norovirus.. |
10/26/2023 | 08:00 | GLOBE | Vaxart to Host Third Quarter 2023 Business Update and.. |
10/23/2023 | 17:09 | EDGAR2 | Form 8-K/A - Current report: [Amend] |
10/23/2023 | 17:01 | EDGAR2 | Form 8-K - Current report |
10/11/2023 | 08:00 | GLOBE | Vaxart to Present at World Vaccine Congress Europe 2023 on.. |
9/21/2023 | 08:00 | GLOBE | Vaxart to Participate in Fireside Chat at 2023 Cantor Global.. |
9/06/2023 | 16:43 | EDGAR2 | Form 8-K - Current report |
9/06/2023 | 16:05 | GLOBE | Vaxart Announces Topline Data from the Phase 2 Challenge.. |
8/03/2023 | 16:30 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
8/03/2023 | 16:20 | EDGAR2 | Form 8-K - Current report |
8/03/2023 | 16:01 | GLOBE | Vaxart Provides Business Update and Reports Second Quarter.. |
8/01/2023 | 21:23 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
8/01/2023 | 21:20 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
8/01/2023 | 21:16 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
8/01/2023 | 21:14 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
8/01/2023 | 20:49 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
7/27/2023 | 08:00 | GLOBE | Vaxart to Host Second Quarter 2023 Business Update and.. |
7/26/2023 | 16:20 | EDGAR2 | Form 8-K - Current report |
7/10/2023 | 16:12 | EDGAR2 | Form 8-K - Current report |
7/06/2023 | 08:00 | GLOBE | Vaxart Announces Positive Preliminary Topline Data from.. |
6/28/2023 | 16:22 | EDGAR2 | Form 8-K - Current report |
6/26/2023 | 16:45 | GLOBE | Vaxart Stockholders Approve All Four Proposals in the 2023.. |
6/21/2023 | 16:30 | GLOBE | Vaxart Encourages All Stockholders of Record as of April 28,.. |
6/07/2023 | 09:16 | GLOBE | Vaxart, Inc. Announces Pricing of $15,000,000 Public.. |
6/06/2023 | 16:01 | GLOBE | Vaxart, Inc. Announces Proposed Public Offering of Common.. |
6/06/2023 | 08:00 | GLOBE | Vaxart Announces Last Subject Dosed in Phase 2 Trial of its.. |
5/31/2023 | 08:00 | GLOBE | Vaxart Launches New Investor Communication Program, First.. |